YOFO at the 2024 Chicago Dental Meeting
YOFO Medical presented Pirox-D Plus at the 2024 Chicago dental exhibition, connecting with dental professionals, distributors and industry partners from across North America.
Following its earlier appearance in New York, Pirox-D Plus attracted visitors interested in experiencing its imaging capabilities, patient-centered design and AI-assisted imaging workflow firsthand.
Experience Pirox-D Plus in Person
At the event, visitors explored a range of Pirox-D Plus capabilities designed around clinical efficiency, image quality and patient experience.

|
Key features presented included:
High Spatial Resolution Up to 28 lp/cm for detailed visualization of anatomical structures.
Low-Dose Imaging Designed to reduce radiation dose by up to 75% while maintaining clinically useful image quality.
Efficient Workflow Fast scanning and reconstruction help support high-throughput clinical environments. |
|
Patient-Centered Design
The seated, open structure provides a more comfortable and accessible scanning experience.
Visitors were also able to review clinical images and experience YOFO’s AI-assisted imaging software, providing a more complete view of the workflow from acquisition to image interpretation.

Connecting with Dental Professionals and Partners
The event provided an opportunity to speak directly with clinicians about their imaging needs and with distributors exploring advanced CBCT solutions for the North American market.
These conversations offered valuable insight into local clinical workflows, product expectations and partnership opportunities, while allowing visitors to experience YOFO technology beyond product specifications alone.
Advancing Precision Imaging Through Global Exchange
Following exhibitions in Dubai and Chicago in early 2024, YOFO continued to expand its engagement with dental professionals and partners in international markets.
For YOFO, events like these are not only an opportunity to present new technology. They are also a way to listen, learn and build imaging solutions around real clinical needs.


40%
80%
300+
20+
1,000+
NO.1





_1.png)
